The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|2|1|71-77

ISSN： 1574-8863

Source： Current Drug Safety, Vol.2, Iss.1, 2007-01, pp. : 71-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New guidelines for hormone-replacement therapy: an update on risks and benefits for clinical practice

By Hamoda Haitham   Savvas Mike   Panay Nick  

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 675-678

Future Medicine

Access to resources Recommend Favorite

Neonatal seizures in hypoxic–ischaemic encephalopathy – risks and benefits of anticonvulsant therapy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 40-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 1-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 23-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Benefits of SMART therapy for asthma management

By  

PRESCRIBER, Vol. 26, Iss. 7, 2015-04 ,pp. : 29-33

John Wiley & Sons Inc

Access to resources Recommend Favorite